-+ 0.00%
-+ 0.00%
-+ 0.00%

Tvardi Therapeutics Q3 EPS $(0.48) Beats $(0.53) Estimate

Benzinga·11/13/2026 12:09:03
Listen to the news
Tvardi Therapeutics (NASDAQ:TVRD) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.53) by 9.43 percent. This is a 18.64 percent increase over losses of $(0.59) per share from the same period last year.